The systemic complement activation cause
โ
Francis D. Moore Jr; Deric D. Schoof; Mary Rodrick; Timothy J. Eberlein
๐
Article
๐
1991
๐
John Wiley and Sons
๐
French
โ 617 KB
Twenty-three cancer patients undergoing therapy with interleukin-2 and lymphokine-activated killer cells were studied for evidence of complement activation and systemic neutrophil activation occurring during the course of therapy. Patient plasma samples demonstrated evidence of marked complement act